2Dong-Yao Zhou,Lian-Ying Lin,Hong Wang,Jian-Sheng Huang the Department of Clinical Laboratory Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China Molecular Biology Diagnostic Center, First Military Medical University, Guangzhou 510515, China.The relationship between HBV lamivudine resistance and HBV genotypes or basic core promoter mutations[J].Hepatobiliary & Pancreatic Diseases International,2003,2(1):85-89. 被引量：5
3Kao J H,Hsu H M,Shau W Y,et al.Universal hepatitis B vac-cination and the decreased mortality from fulminant hepatitis ininfants in taiwan[J].J Pediatr,2001,139(3):349-352.
4Chen H L,Chang C J,Kong M S,et al.Pediatric fulminant he-patic failure in endemic areas of hepatitis B infection:15yearsafter universal hepatitis B vaccination[J].Hepatology,2004,39(1):58-63.
5Bhimma R,Coovadia H M,Adhikari M,et al.The impact of thehepatitis B virus vaccine on the incidence of hepatitis B virus-associated membranous nephropathy[J].Arch Pediatr AdolescMed,2003,157(10):1025-1030.
6Severini A,Liu X Y,Wilson J S,et al.Mechanism of inhibitionof duck hepatitis B virus polymerase by(-)-beta-L-2′,3′-dideoxy-3′-thiacytidine[J].Antimicrob Agents Chemother,1995,39(7):1430-1435.
8Jonas M M,Mizerski J,Badia I B,et al.Clinical trial of lamivu-dine in children with chronic hepatitis B[J].N Engl J Med,2002,346(22):1706-1713.
9Sokal E M,Kelly D A,Mizerski J,et al.Long-term lamivudinetherapy for children with HBeAg-positive chronic hepatitis B[J].Hepatology,2006,43(2):225-232.
10Lizio G,Sterrantino AF,Ragazzini S,et al.Volume reduction of cystic lesions after surgical decompression:a computerised three-dimensional computed tomographic evaluation[J].Clin Oral Investig,2013,17(7):1701-1708.
